Use of cyclosporine in children and adolescents with moderate to severe atopic dermatitis: clinical experience in a tertiary Hospital

被引：0

作者：

Proenca, Carolina Contin ^{[1
]}

Mayor, Silvia Assumpcao Soutto ^{[1
]}

Ragazzo, Thais Storni ^{[1
]}

Munhoz, Sandy Daniele Germano ^{[1
]}

Pires, Carolina Gadelha ^{[1
]}

机构：

[1] Dermatol Clin, Santa Casa Sao Paulo, Sao Paulo, SP, Brazil

来源：

ANAIS BRASILEIROS DE DERMATOLOGIA | 2023年 / 98卷 / 04期

关键词：

D O I：

10.1016/j.abd.2022.10.006

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：526 / 528

页数：3

共 50 条

[21] Real-life experience with dupilumab in 56 children and adolescents aged 2 to 17 with uncontrolled moderate-to-severe atopic dermatitis [J].

Colonna, Cristiana ;

Monzani, Nicola A. ;

Quattri, Eleonora ;

Montefusco, Francesca ;

Cavalli, Riccardo .

ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 159 (06) :694-695

[22] Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre [J].

Firas Constantin Kreeshan ;

Ali Al-Janabi ;

Richard Bruce Warren ;

Hamish John Alexander Hunter .

Dermatology and Therapy, 2021, 11 :149-160

[23] Moderate/severe atopic dermatitis: Report of experience with methotrexate in childhood and adolescence [J].

Goudouris, E. ;

Prado, E. ;

Lira, C. ;

Mariz, F. P. ;

Silveira, H. ;

Motta, M. F. M. .

ALLERGY, 2018, 73 :833-833

[24] Upadacitinib for moderate to severe atopic dermatitis [J].

Navarro-Trivino, Francisco ;

Alcantara-Luna, Sara ;

Dominguez-Cruz, Javier ;

Galan-Gutierrez, Manuel ;

Ruiz-Villaverde, Ricardo ;

Pereyra-Rodriguez, Jose-Juan ;

Armario-Hita, Jose-Carlos .

IMMUNOTHERAPY, 2023, 15 (11) :799-808

[25] Importance of concomitant topical therapy in moderate-to-severe atopic dermatitis treated with cyclosporine [J].

Kim, Jeong Eun ;

Shin, Jae Min ;

Ko, Joo Yeon ;

Ro, Young Suck .

DERMATOLOGIC THERAPY, 2016, 29 (02) :120-125

[26] Clinical features associated with nasal Staphylococcus aureus colonization in children with moderate to severe atopic dermatitis [J].

Hon, KLE ;

Lam, MCA ;

Leung, TF ;

Kam, WYC ;

Li, AM ;

Fok, TF .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 :88-88

[27] Proactive use of tacrolimus 0.03% ointment in children with moderate or severe atopic dermatitis -: Outcomes and cost [J].

Thaci, D. ;

Sidhu, M. ;

Dorsch, B. ;

Koehne-Volland, R. ;

Ehlken, B. ;

Berger, K. .

VALUE IN HEALTH, 2008, 11 (03) :A291-A291

[28] CYCLOSPORINE THERAPY FOR SEVERE ATOPIC-DERMATITIS [J].

TAYLOR, RS ;

COOPER, KD ;

HEADINGTON, JT ;

HO, VC ;

ELLIS, CN ;

VOORHEES, JJ .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (03) :580-583

[29] A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis [J].

Napolitano, Maddalena ;

Fabbrocini, Gabriella ;

Potestio, Luca ;

Fontanella, Giuseppina ;

Picone, Vincenzo ;

Bennardo, Luigi ;

Scalvenzi, Massimiliano ;

Patruno, Cataldo .

DERMATOLOGIC THERAPY, 2022, 35 (08)

[30] Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children [J].

Parker, Jennifer J. ;

Sugarman, Jeffrey L. ;

Silverberg, Nanette B. ;

Gonzalez, Mercedes Elena ;

Ramien, Michele L. ;

Teng, Joyce M. C. ;

Paller, Amy S. .

PEDIATRIC DERMATOLOGY, 2021, 38 (06) :1500-1505

← 1 2 3 4 5 →